P

Inventor

VALTON JULIEN

US20 patents
⚠️ This page may combine multiple inventors who share the name “VALTON JULIEN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

CELLECTIS

15 patents
US10239948B2Mar 26, 2019

Method of engineering multi-input signal sensitive T cell for immunotherapy

CELLECTIS16 citations84
US11014989B2May 25, 2021

Anti-CLL1 specific single-chain chimeric antigen receptors (scCARs) for cancer immunotherapy

CELLECTIS2 citations73
US11186824B2Nov 30, 2021

Methods for engineering allogeneic T cell to increase their persistence and/or engraftment into patients

CELLECTIS4 citations72
US11220683B2Jan 11, 2022

Method to overcome DNA chemical modifications sensitivity of engineered TALE DNA binding domains

CELLECTIS0 citations62
US10526406B2Jan 7, 2020

Chimeric antigen receptor using antigen recognition domains derived from cartilaginous fish

CELLECTIS1 citations62
US12391933B2Aug 19, 2025

Targeted gene insertion for improved immune cells therapy

CELLECTIS0 citations61
US12209125B2Jan 28, 2025

Targeted gene integration of NK inhibitors genes for improved immune cells therapy

CELLECTIS0 citations61
US11873511B2Jan 16, 2024

Targeted gene insertion for improved immune cells therapy

CELLECTIS0 citations61
US11136566B2Oct 5, 2021

Tale-protein scaffolds and uses thereof

CELLECTIS0 citations60
US11903968B2Feb 20, 2024

Engineered immune cells resistant to tumor microenvironment

CELLECTIS0 citations59
US11198856B2Dec 14, 2021

Method for the generation of compact tale-nucleases and uses thereof

CELLECTIS0 citations59
US12221478B2Feb 11, 2025

Targeted gene integration of CRS inhibitor genes for improved immune cells therapy

CELLECTIS0 citations58
US10894093B2Jan 19, 2021

Method of engineering drug-specific hypersensitive t-cells for immunotherapy by gene inactivation

CELLECTIS0 citations52
US10813951B2Oct 27, 2020

Method of engineering chemotherapy drug resistant T-cells for immunotherapy

CELLECTIS0 citations50
US10472396B2Nov 12, 2019

Modular base-specific nucleic acid binding domains from burkholderia rhizoxinica proteins

CELLECTIS0 citations48

PFIZER

3 patents

DUCHATEAU PHILIPPE

1 patent

CELLECTIS SA

1 patent